Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration - PubMed (original) (raw)

Review

Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration

Jorge M A Oliveira. J Bioenerg Biomembr. 2010 Jun.

Abstract

Preferential striatal neurodegeneration is a hallmark of Huntington's disease (HD) pathogenesis, which has been associated with mitochondrial dysfunction. Evidence from genetic HD models suggest that mutant huntingtin (mHtt) compromises mitochondrial bioenergetics and dynamics, preventing efficient calcium handling and ATP generation in neuronal networks. Striatal neurons receive abundant glutamatergic input from the cortex, forming tripartite synapses with astrocytic partners. These are involved in bidirectional communication, play neuroprotective roles, and emerging evidence suggests that astrocyte dysfunction supports non-cell autonomous neurodegeneration. In addition to mHtt effects, inherent mitochondria vulnerability within striatal neurons and astrocytes may contribute for preferential neurodegeneration in HD. Dysfunctional astrocytic mitochondria in cortico-striatal tripartite synapses might be particularly relevant in the pathogenesis of juvenile/infantile HD, frequently associated with seizures and abnormally large mHtt polyglutamine expansions. This review discusses our work, primarily addressing in situ mitochondrial function in neurons and astrocytes, in the context of related work within the HD-mitochondria field.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann N Y Acad Sci. 2008 Dec;1147:358-82 - PubMed
    1. Neurobiol Dis. 2006 May;22(2):388-400 - PubMed
    1. Neurology. 2000 Nov 14;55(9):1249-55 - PubMed
    1. J Bioenerg Biomembr. 2006 Feb;38(1):43-7 - PubMed
    1. J Biol Chem. 2004 Jul 30;279(31):32989-3000 - PubMed

Publication types

MeSH terms

LinkOut - more resources